Author:
Levy Moshe,Xie Lin,Wang Yuexi,Neumann Frank,Srivastava Shouryadeep,Naranjo Daniel,Xu Jing,Zhang Qisu,Dalal Mehul
Funder
Takeda Pharmaceuticals U.S.A.
Reference36 articles.
1. Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology;O'Donnell;J. Natl. Compr. Canc. Netw.,2017
2. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring;Jabbour;Am. J. Hematol.,2018
3. Mechanisms of disease progression and resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update;Bavaro;Int. J. Mol. Sci.,2019
4. Natural course and biology of CML;Chereda;Ann. Hematol.,2015
5. Cancer Stat Facts [Internet]. Bethesda (MD): the national institute of health: national cancer institute; c1887–2020. Leukemia - chronic myeloid leukemia (cml) [cited 2020 mar 16]; [about 4 screens]. Available from: seer.cancer.gov/statfacts/html/cmyl.html.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献